Press Releases - Debiopharm

Press Releases

15 May 2012
Debiopharm and Vifor Pharma sign an exclusive agreement for the distribution and commercialization of Pamorelin® LA in Switzerland - A drug treatment for prostate cancer and endometriosis
16 February 2012
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
09 November 2011
Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease
05 October 2011
The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer
08 September 2011
Debiopharm Group™ presents the ‘Debiopharm Group™ Life Sciences Award 2011’ and two ‘Junior Debiopharm Group™ Awards 2011’ at the ISREC 2011 Life Sciences Symposium

Older »

1/31

Tremelimumab - codevelopment with Pfizer Inc ( 1 Article )
Debio 0931 ( 1 Article )
Debio 0932 ( 3 Articles )
Debio 0930 ( 1 Article )
Debio 0929 ( 1 Article )
Debio 0928 ( 1 Article )
Debio 0827 ( 1 Article )
Debio 0826 ( 1 Article )
Triptorelin – Trelstar® – Decapeptyl® - Pamorelin® ( 15 Articles )
Debio 8609 Sanvar® ( 13 Articles )
Debio 025 ( 9 Articles )
Debio 9902 - ZT-1 ( 9 Articles )
Debio 0614 (istaroxime) ( 2 Articles )
Debio 0507 ( 3 Articles )
Debio 0719 ( 1 Article )
Debio 0617 ( 3 Articles )
Oxaliplatin – Eloxatin® – Elplat® ( 10 Articles )
Moapar® - Salvacyl® ( 5 Articles )
Debio 1036 ( 1 Article )
Other News ( 67 Articles )
Debio 1141 ( 1 Article )
Debio 1142 ( 1 Article )
Debio 1143 ( 1 Article )

Latest News

15 May 2012 Debiopharm and Vifor Pharma sign an exclusive agreement for the distribution and commercialization of Pamorelin® LA in Switzerland - A drug treatment for prostate cancer and endometriosis

16 February 2012 Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932

09 November 2011 Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease

Debiopharm on

© 2012 Debiopharm Group